- Home
- LODE vs ELTX Comparison
LODE vs ELTX Comparison
Compare LODE & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LODE | ELTX |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.0M | 158.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LODE | ELTX |
|---|---|---|
| Price | $3.59 | $9.33 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $4.00 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 968.9K | 106.0K |
| Earning Date | 10-30-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,778,445.00 | N/A |
| Revenue This Year | $7.65 | N/A |
| Revenue Next Year | $1,093.72 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 48.99 | N/A |
| 52 Week Low | $1.67 | $4.60 |
| 52 Week High | $10.10 | $12.62 |
Technical Indicators
Market Signals| Indicator | LODE | ELTX |
|---|---|---|
| Relative Strength Index (RSI) | 59.40 | 54.27 |
| Support Level | $3.04 | $7.87 |
| Resistance Level | $3.61 | $8.99 |
| Average True Range (ATR) | 0.24 | 0.49 |
| MACD | 0.07 | 0.12 |
| Stochastic Oscillator | 86.59 | 88.99 |
Price Performance
Historical ComparisonAbout LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.